Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 11-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,791 | -4,869 | -30,344 | -11 | -16,813 |
| Depreciation Amortization | 105 | 52 | 125 | N/A | 73 |
| Accounts payable and accrued liabilities | 312 | -2,751 | 2,979 | 2 | 675 |
| Other Working Capital | 216 | -2,864 | 3,114 | 2 | 636 |
| Other Operating Activity | 2,371 | 5,852 | 21,389 | 7 | 13,339 |
| Operating Cash Flow | $-6,787 | $-4,579 | $-2,737 | $0 | $-2,089 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,300 | -1,300 | N/A | N/A | N/A |
| PPE Investments | -10 | -7 | -25 | N/A | -9 |
| Purchase Of Investment | N/A | N/A | -373 | N/A | -399 |
| Purchase Sale Intangibles | -6 | N/A | -1,168 | N/A | -1,158 |
| Other Investing Activity | -6 | 0 | -1,302 | 0 | -1,161 |
| Investing Cash Flow | $-1,315 | $-1,307 | $-1,700 | $N/A | $-1,569 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 930 | N/A | 930 |
| Common Stock Issued | 9,276 | 9,276 | 3,476 | N/A | 2,765 |
| Other Financing Activity | -898 | -898 | 32 | 0 | -45 |
| Financing Cash Flow | $8,378 | $8,378 | $4,438 | $N/A | $3,650 |
| Beginning Cash Position | 11 | 11 | 10 | 4 | 10 |
| End Cash Position | 287 | 2,504 | 11 | 4 | 2 |
| Net Cash Flow | $275 | $2,492 | $1 | $0 | $-8 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,787 | -4,579 | -2,737 | 0 | -2,089 |
| Capital Expenditure | -10 | -7 | -25 | N/A | -9 |
| Free Cash Flow | -6,797 | -4,585 | -2,762 | 0 | -2,097 |